Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Butyrolactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed route for high-purity gamma-butyrolactone derivatives with superior enantioselectivity and scalable manufacturing capabilities for global pharma supply chains.
Patent CN101250171A details a chiral phosphine-catalyzed method for gamma-butyrolactones, offering high ee values and yield for pharmaceutical intermediate manufacturing.
Novel biomass route for GBL production offering cost reduction and supply chain reliability for fine chemical intermediate manufacturing.
Patent CN113336726B details a novel synthesis of (R)-3-propyl-γ-butyrolactone using chiral auxiliaries, offering high purity and cost-effective manufacturing for API intermediates.
Patent CN114213367A details a novel nickel-catalyzed route to gamma-butyrolactone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Novel patent CN105461671B enables cost-effective high-purity intermediate production with simplified supply chain and scalable manufacturing processes for global buyers.
Patent CN107663185A reveals a cost-effective titanium-zinc catalyzed route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Patent CN107663185A reveals a low-cost titanium-zinc catalytic route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Novel titanium-zinc method for butyrolactone derivative ensures high purity and scalable supply chain for epilepsy drug intermediates globally.
Patent CN107827844A details a cost-effective synthesis route for butyrolactone derivatives. This method offers significant supply chain advantages and high purity for pharmaceutical manufacturing.
Patent CN107759540A reveals a cost-effective three-step synthesis for butyrolactone derivatives, offering significant supply chain advantages for pharmaceutical manufacturers.
Novel liquid sodium methoxide process boosts yield to 96%, enhancing safety and supply chain reliability for pharmaceutical intermediates.
Patent CN104250236A details efficient CuH catalyzed lactone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced Sharpless epoxidation process for (S)-beta-hydroxy-gamma-butyrolactone. Delivers high enantiomeric excess and cost-effective supply chain solutions for pharmaceutical manufacturing.
Patent CN1265092A details a continuous aqueous process for L-carnitine using (S)-3-activated hydroxybutyrolactone, offering high purity and cost efficiency.
Patent CN117586211B discloses a copper-catalyzed method for beta-ester-gamma-butyrolactone offering high selectivity and cost-effective supply chain solutions.
Patent CN104651425A enables high-purity lactone production with reduced costs and enhanced supply chain reliability for flavor manufacturers globally.